Technical Analysis for RHHBY - Roche Hldg Ltd Spons

Grade Last Price % Change Price Change
grade A 42.39 -0.45% -0.1900
RHHBY closed down 0.45 percent on Thursday, January 23, 2020, on 33 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Up
Historical RHHBY trend table...

Date Alert Name Type % Chg
180 Bullish Setup Bullish Swing Setup 0.00%
Slingshot Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
Overbought Stochastic Strength 0.00%
Gapped Down Weakness 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup -0.45%
MACD Bullish Signal Line Cross Bullish -0.45%
New 52 Week Closing High Bullish -0.45%
Narrow Range Bar Range Contraction -0.45%
Older signals for RHHBY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Life Sciences Pharmaceutical Industry In China Pharmaceutical Products Infectious Diseases Disease Neuroscience Gene Expression Genentech Hoffmann La Roche Diabetes Care Chugai Pharmaceutical Co. Roche

Is RHHBY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 42.88
52 Week Low 25.1
Average Volume 1,178,930
200-Day Moving Average 35.7176
50-Day Moving Average 39.2184
20-Day Moving Average 40.4205
10-Day Moving Average 40.1580
Average True Range 2.0691
ADX 54.47
+DI 6.0863
-DI 44.8577
Chandelier Exit (Long, 3 ATRs ) 36.6727
Chandelier Exit (Short, 3 ATRs ) 38.2292
Upper Bollinger Band 45.1011
Lower Bollinger Band 35.7399
Percent B (%b) 0.71
BandWidth 23.1595
MACD Line 0.5961
MACD Signal Line 0.4159
MACD Histogram 0.1802
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 42.7650
Resistance 3 (R3) 42.7367 42.5833 42.7025
Resistance 2 (R2) 42.5833 42.4878 42.5975 42.6817
Resistance 1 (R1) 42.4867 42.4288 42.5350 42.5150 42.6608
Pivot Point 42.3333 42.3333 42.3575 42.3475 42.3333
Support 1 (S1) 42.2367 42.2378 42.2850 42.2650 42.1192
Support 2 (S2) 42.0833 42.1788 42.0975 42.0984
Support 3 (S3) 41.9867 42.0833 42.0775
Support 4 (S4) 42.0150